FDA Approved Mobile Mammography Screening Device
Mobile Mammography Screening Device
GE Healthcare on Wednesday announced that it has received FDA approval for its mobile mammography screening device, Reuters reports. The device will make it easier to increase screening for breast cancer in rural areas, Reuters reports (Reuters, 8/22). According to a GE release, the Senographe Essential device will improve access to mammography screening worldwide (GE release, 8/22).
According to a study published in the June 15 issue of the journal Cancer,the proportion of U.S. women age 40 and older who said they haveundergone a mammogram in the previous two years declined from 70% to66% from 2000 to 2005 (Kaiser Daily Women's Health Policy Report, 5/14).
"GE'sgoal is to enhance breast care for women worldwide and bring thistechnology to those who otherwise would not have access to it," DavidCaumartin, general manager of Global Mammography for GE Healthcare,said. He added, "GE offers customers the broadest portfolio when itcomes to breast imaging, and the new mobile Essential will be thetop-of-the-line mobile product in the market featuring all the provenadvantages of our Senographe platform" (GE release, 8/22).
Reprinted with permission from kaisernetwork.org. You can view theentire Kaiser DailyWomen's Health Policy Report, search the archives, and sign up for emaildelivery at kaisernetwork.org/email. The Kaiser Daily Women's Health Policy Report is published for kaisernetwork.org, afree service of The Henry J. Kaiser Family Foundation.